Stock Ideas
New
StocksFundsScreenerSectorsWatchlists
DVA

DVA - DaVita Inc Stock Price, Fair Value and News

134.45USD-7.79 (-5.48%)Market Closed

Market Summary

DVA
USD134.45-7.79
Market Closed
-5.48%

DVA Alerts

  • Big jump in Earnings (Y/Y)

DVA Stock Price

View Fullscreen

DVA RSI Chart

DVA Valuation

Market Cap

11.8B

Price/Earnings (Trailing)

14.46

Price/Sales (Trailing)

0.96

EV/EBITDA

9.75

Price/Free Cashflow

12.81

DVA Price/Sales (Trailing)

DVA Profitability

EBT Margin

10.81%

Return on Equity

88.08%

Return on Assets

4.68%

Free Cashflow Yield

7.81%

DVA Fundamentals

DVA Revenue

Revenue (TTM)

12.3B

Rev. Growth (Yr)

6.89%

Rev. Growth (Qtr)

-2.39%

DVA Earnings

Earnings (TTM)

815.6M

Earnings Growth (Yr)

107.4%

Earnings Growth (Qtr)

59.06%

Breaking Down DVA Revenue

Last 7 days

7.1%

Last 30 days

5.3%

Last 90 days

27.9%

Trailing 12 Months

61.3%

How does DVA drawdown profile look like?

DVA Financial Health

Current Ratio

1.43

Debt/Equity

9.72

Debt/Cashflow

0.16

DVA Investor Care

Buy Backs (1Y)

3.31%

Diluted EPS (TTM)

8.81

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202412.3B000
202311.7B11.7B11.9B12.1B
202211.6B11.6B11.6B11.6B
202111.5B11.6B11.6B11.6B
202011.5B11.5B11.5B11.6B
201911.3B11.3B11.3B11.4B
201811.1B11.3B11.4B11.4B
201710.7B10.8B10.8B10.9B
201610.2B10.3B10.5B10.7B
201513.0B13.3B13.6B10.0B
201412.0B12.3B12.5B12.8B
20139.2B10.1B11.2B11.8B
20127.1B7.4B7.6B8.2B
20116.4B6.5B6.6B6.8B
20106.2B6.3B6.4B6.4B
20095.8B5.9B6.0B6.1B
200805.4B5.5B5.7B
20070005.3B
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022


Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of DaVita Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 15, 2024
waters kathleen alyce
sold (taxes)
-1,098,740
136
-8,079
chief legal & pub. affairs off
Mar 15, 2024
staffieri michael david
acquired
-
-
13,172
chief operating officer, dkc
Mar 15, 2024
desoer barbara j
acquired
-
-
366
-
Mar 15, 2024
schoppert wendy lee
acquired
-
-
366
-
Mar 15, 2024
nehra john m
acquired
-
-
366
-
Mar 15, 2024
hearty james o
sold (taxes)
-329,800
136
-2,425
chief compliance officer
Mar 15, 2024
arway pamela m
acquired
-
-
366
-
Mar 15, 2024
staffieri michael david
sold (taxes)
-1,633,090
136
-12,008
chief operating officer, dkc
Mar 15, 2024
berg charles
acquired
-
-
366
-
Mar 15, 2024
berry christopher michael
acquired
-
-
3,659
chief accounting officer

1–10 of 50

Which funds bought or sold DVA recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 02, 2024
WHITTIER TRUST CO
reduced
-7.13
163,226
892,354
0.01%
May 02, 2024
WHITTIER TRUST CO OF NEVADA INC
reduced
-22.86
5,072
312,542
0.01%
May 02, 2024
Sumitomo Mitsui DS Asset Management Company, Ltd
added
8.47
219,336
730,146
0.01%
May 02, 2024
Peregrine Asset Advisers, Inc.
new
-
207,075
207,075
0.08%
May 02, 2024
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC
reduced
-2.13
219,527
977,256
0.01%
May 02, 2024
NORDEA INVESTMENT MANAGEMENT AB
reduced
-3.49
9,341,590
43,480,300
0.05%
May 02, 2024
State of New Jersey Common Pension Fund D
unchanged
-
1,031,120
4,275,960
0.01%
May 02, 2024
Quent Capital, LLC
added
21.04
29,922
80,207
0.01%
May 02, 2024
FinTrust Capital Advisors, LLC
added
17.56
40,959
115,549
0.02%
May 02, 2024
TOBAM
reduced
-14.31
1,844,000
16,115,000
1.44%

1–10 of 46

Are Funds Buying or Selling DVA?

Are funds buying DVA calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own DVA
No. of Funds

Unveiling DaVita Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 16, 2024
berkshire hathaway inc
41.2%
36,095,570
SC 13D/A
Feb 13, 2024
vanguard group inc
6.92%
6,320,740
SC 13G/A
Jan 31, 2024
blackrock inc.
5.2%
4,790,419
SC 13G/A
Feb 09, 2023
vanguard group inc
6.84%
6,166,112
SC 13G/A
Feb 01, 2023
blackrock inc.
5.4%
4,822,086
SC 13G/A
Feb 14, 2022
berkshire hathaway inc
37.5%
36,095,570
SC 13D/A
Feb 09, 2022
vanguard group inc
7.34%
7,481,018
SC 13G/A
Feb 01, 2022
blackrock inc.
5.5%
5,654,952
SC 13G/A
Aug 04, 2021
berkshire hathaway inc
34.4%
36,095,570
SC 13D/A
Feb 16, 2021
berkshire hathaway inc
33.0%
36,095,570
SC 13D/A

Recent SEC filings of DaVita Inc

View All Filings
Date Filed Form Type Document
May 02, 2024
10-Q
Quarterly Report
May 02, 2024
8-K
Current Report
May 01, 2024
8-K
Current Report
Apr 26, 2024
ARS
ARS
Apr 26, 2024
DEF 14A
DEF 14A
Apr 26, 2024
DEFA14A
DEFA14A
Apr 16, 2024
3
Insider Trading
Apr 10, 2024
8-K
Current Report
Mar 19, 2024
4
Insider Trading
Mar 19, 2024
4
Insider Trading

Peers (Alternatives to DaVita Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
454.0B
371.6B
7.68% 0.79%
20.29
1.22
14.64% 11.24%
97.0B
206.0B
-5.16% 39.98%
25.17
0.47
12.55% -43.95%
80.6B
66.7B
-6.23% 11.01%
14.74
1.21
9.59% -4.59%
70.2B
360.9B
-25.25% -21.26%
9.58
0.19
9.07% 78.49%
39.9B
155.5B
2.59% 8.16%
14.6
0.26
6.34% 84.42%
11.8B
12.3B
5.32% 61.32%
14.46
0.96
5.77% 58.74%
11.6B
14.3B
-1.51% 19.13%
16.19
0.81
6.59% 6.24%
MID-CAP
8.5B
2.3B
-12.14% 1.66%
30
3.71
5.96% 18.29%
6.1B
3.0B
-11.92% -1.82%
-542.9
2.05
10.92% -104.06%
2.3B
3.8B
3.30% -28.74%
10.69
0.59
-27.73% -52.50%
2.1B
1.4B
-11.91% 5.74%
34.19
1.5
21.19% 34.42%
SMALL-CAP
1.6B
1.1B
-3.20% 17.84%
25.46
1.5
11.31% 35.83%
1.4B
3.0B
10.43% 83.67%
-7.5
0.47
6.74% 20.73%
58.7M
-
5.26% -4.76%
-4.01
-
- -12.94%
18.5M
21.3M
- 6.55%
34.8
0.87
8.00% -62.25%

DaVita Inc News

Latest updates
Yahoo Finance • 10 hours ago
Yahoo Lifestyle Australia • 17 hours ago
MarketWatch • 01 May 2024 • 09:19 pm
Markets Insider • 01 May 2024 • 03:43 pm
MarketWatch • 30 Apr 2024 • 09:20 pm

DaVita Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-2.4%3,0713,1463,1213,0002,8732,9172,9492,9272,8182,9442,9382,9172,8202,9052,9242,8802,8412,8992,9042,8432,743
Costs and Expenses-6.1%2,5872,7562,6252,5952,5612,6612,6372,4942,4792,5552,4632,4262,3772,5242,4862,4702,3762,4362,5262,3812,403
  S&GA Expenses-100.0%-401377364332380365315295323293298281305363316264278299275251
EBITDA Margin6.9%0.17*0.16*0.15*0.14*0.14*0.15*0.16*0.17*0.18*0.19*0.19*0.18*---------
Income Taxes12.5%66.0058.0069.0049.0044.0034.0043.0064.0057.0066.0075.0081.0085.0073.0066.0083.0092.0082.0065.0076.0057.00
Earnings Before Taxes28.6%372289378295215147207349263315394432377327283338369382274324216
EBT Margin11.5%0.11*0.10*0.09*0.07*0.08*0.08*0.10*0.11*0.12*0.13*0.13*0.12*---------
Net Income59.1%24015124717911668.00105225162187260294237174159202240245143274149
Net Income Margin16.1%0.07*0.06*0.05*0.04*0.04*0.05*0.06*0.07*0.08*0.08*0.08*0.07*---------
Free Cashflow-178.4%-25532652432631515056746.00199340409530---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets3.2%17,43116,89416,92916,95916,72816,92816,96217,10117,08717,12117,63417,81017,64716,98917,04719,30517,59617,31117,45219,93122,606
  Current Assets17.4%3,6843,1383,1353,0023,0403,1553,2023,2643,1293,1683,8403,9793,8673,1493,4305,7804,0243,6903,9996,3919,225
    Cash Equivalents13.3%4313804493273172444623564215551,1391,2061,0615028173,0361,4881,2091,3573,682561
  Inventory1.9%14614311011010710910711010810711411511611210698.0096.0098.0099.0097.00104
  Net PPE-1.5%3,0263,0743,0973,1583,2163,2563,2403,3053,4393,4803,4633,4863,4903,5223,4183,4183,4453,4733,4193,4053,392
  Goodwill1.6%7,2307,1137,0887,1067,0907,0777,0237,0207,0737,0466,9416,9446,8916,9196,8686,7916,7786,7886,7666,8656,799
Liabilities4.6%14,79514,15014,10414,32914,30914,70314,88914,94014,67814,75114,88214,92114,86514,09213,98915,72914,23513,81213,64314,50217,376
  Current Liabilities-2.2%2,5832,6422,5382,4032,5652,6202,5372,3112,4202,3992,3632,3862,3152,4762,4994,2752,2212,3722,2075,7078,231
  Long Term Debt8.9%9,0018,2688,2858,5988,4188,6938,8679,0658,6878,7298,7718,7988,8307,9177,8677,8958,4427,9788,0145,3785,787
Shareholder's Equity-12.3%9261,0561,1991,0178257125331705953541,1491,3841,0901832,0322,1541,9481860.004,049990
  Retained Earnings40.1%8385987154692901748477415163541,6441,3841,0908532,0321,8731,6711,4323,3493,2062,932
  Additional Paid-In Capital-16.0%428510553556590607609578595540525523603597694719720749907989990
Shares Outstanding1.1%90.0089.0091.0091.0091.0090.0094.0094.0096.00105105106---------
Minority Interest9.9%207188180189194164169170175181179185185183179180185186194194211
Float----9,200---7,400---12,700---9,700---9,300-
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-127.8%-134485661450463344711188322530567680154485483651360681641610141
  Share Based Compensation-18.4%25.0030.0027.0030.0025.0018.0028.0025.0025.0026.0024.0028.0024.0024.0025.0022.0020.0020.0019.0017.0012.00
Cashflow From Investing-27.9%-215-168-139-347-116-213-153-144-118-336-164-159-124-338-80.17-244-162-138-2683,603-200
Cashflow From Financing179.2%319-403-394-96.84-275-230-445-103-341-774-464-381537-465-2,6211,14397.00-692-2,693-1,635325
  Buy Backs-7.8%251272----185381236656322244316433704-3225471,76473.00-
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

DVA Income Statement

2024-03-31
CONSOLIDATED STATEMENTS OF INCOME (unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]  
Dialysis patient service revenues$ 2,941,532$ 2,760,034
Other revenues129,023112,665
Total revenues3,070,5552,872,699
Operating expenses:  
Patient care costs2,078,9762,058,189
General and administrative362,480331,614
Depreciation and amortization187,083178,071
Equity investment income, net(6,682)(6,820)
Gain on changes in ownership interest(35,147)0
Total operating expenses2,586,7102,561,054
Operating income483,845311,645
Debt expense(99,418)(100,774)
Other (loss) income, net(12,641)3,752
Income before income taxes371,786214,623
Income tax expense65,80643,955
Net income305,980170,668
Less: Net income attributable to noncontrolling interests(66,331)(55,121)
Net income attributable to DaVita Inc.$ 239,649$ 115,547
Earnings per share attributable to DaVita Inc.:  
Basic net income$ 2.73$ 1.28
Diluted net income$ 2.65$ 1.25
Weighted average shares for earnings per share:  
Basic shares87,775,00090,497,000
Diluted shares90,547,00092,483,000

DVA Balance Sheet

2024-03-31
CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
ASSETS  
Cash and Cash Equivalents, at Carrying Value$ 345,131$ 380,063
Restricted Cash and Cash Equivalents85,65084,571
Short-term investments10,61111,610
Accounts receivable, net2,594,6751,986,856
Inventories145,808143,105
Other receivables396,399422,669
Prepaid and other current assets105,479102,645
Income tax receivable06,387
Total current assets3,683,7533,137,906
Property and equipment, net3,026,1703,073,533
Operating lease right-of-use assets2,487,1582,501,364
Intangible assets, net201,433203,224
Equity method and other investments492,541545,848
Long-term investments47,72947,890
Other long-term assets262,449271,253
Goodwill7,229,7027,112,560
Total assets17,430,93516,893,578
LIABILITIES AND EQUITY  
Accounts payable489,883514,533
Other liabilities859,604828,878
Accrued compensation and benefits622,127752,598
Current portion of operating lease liabilities401,371394,399
Current portion of long-term debt127,616123,299
Income tax payable82,50028,507
Total current liabilities2,583,1012,642,214
Long-term operating lease liabilities2,311,9022,330,389
Long-term debt9,000,5948,268,334
Other long-term liabilities179,806183,074
Deferred income taxes719,545726,217
Total liabilities14,794,94814,150,228
Commitments and contingencies:  
Noncontrolling interests subject to put provisions1,503,4741,499,288
Equity:  
Preferred Stock, Value, Issued00
Common Stock, Value, Issued9089
Additional paid-in capital428,202509,804
Retained earnings837,937598,288
Treasury Stock, Value(240,117)0
Accumulated other comprehensive loss(100,115)(52,084)
Total DaVita Inc. shareholders' equity925,9971,056,097
Noncontrolling interests not subject to put provisions206,516187,965
Total equity1,132,5131,244,062
Total liabilities and equity$ 17,430,935$ 16,893,578
DVA
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
 CEO
 WEBSITEdavita.com
 INDUSTRYHealthcare Plans
 EMPLOYEES65535

DaVita Inc Frequently Asked Questions


What is the ticker symbol for DaVita Inc? What does DVA stand for in stocks?

DVA is the stock ticker symbol of DaVita Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of DaVita Inc (DVA)?

As of Thu May 02 2024, market cap of DaVita Inc is 12.47 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of DVA stock?

You can check DVA's fair value in chart for subscribers.

What is the fair value of DVA stock?

You can check DVA's fair value in chart for subscribers. The fair value of DaVita Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of DaVita Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for DVA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is DaVita Inc a good stock to buy?

The fair value guage provides a quick view whether DVA is over valued or under valued. Whether DaVita Inc is cheap or expensive depends on the assumptions which impact DaVita Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for DVA.

What is DaVita Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu May 02 2024, DVA's PE ratio (Price to Earnings) is 15.29 and Price to Sales (PS) ratio is 1.01. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. DVA PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on DaVita Inc's stock?

In the past 10 years, DaVita Inc has provided 0.078 (multiply by 100 for percentage) rate of return.